Flupenthixol Treatment in Schizophrenic Cocaine Abusers - 1

Phase 2

Completed

• Conditions: Cocaine-Related Disorders

• Registration Number: NCT00000266
• Lead Sponsor: National Institute on Drug Abuse (NIDA)

Brief Summary

The purpose of this study is to evaluate the safety and efficacy of flupenthixol for cocaine dependence in individuals with schizophrenia/schizoaffective illness.

Detailed Description

Not available

Study Timeline

• Study Start: 1994-08
• Study First Submitted: 1999-09-20
• Study First Submitted QC: 1999-09-20
• Study First Posted: 1999-09-21
• Study Completion: 2001-12
• Status Verified: 2016-10
• Last Update Submitted: 2017-01-11
• Last Update Posted: 2017-01-12

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Drug use
Psychiatric symptoms
Side effects
Craving

Trial Locations

Locations (1)

New York State Psychiatric Institute; 🇺🇸 New York, New York, United States